TY - JOUR
T1 - Congenital anomalies in children with postneonatally acquired cerebral palsy
T2 - an international data linkage study
AU - The Comprehensive CA-CP Study Group
AU - Goldsmith, Shona
AU - McIntyre, Sarah
AU - Scott, Heather
AU - Himmelmann, Kate
AU - Smithers-Sheedy, Hayley
AU - Andersen, Guro L.
AU - Blair, Eve
AU - Badawi, Nadia
AU - Garne, Ester
AU - Barisic, Ingeborg
AU - Bosnjak Mejaski, Vlatka
AU - Amar, Emmanuelle
AU - Sellier, Elodie
AU - Hollung, Sandra Julsen
AU - Klungsøyr, Kari
AU - Braz, Paula
AU - Virella, Daniel
AU - Gibson, Catherine
AU - Källén, Karin
AU - Reid, Susan M.
AU - Baynam, Gareth
AU - Gration, Dylan
AU - Hansen, Michèle
AU - Watson, Linda
AU - Uldall, Peter
N1 - Publisher Copyright:
© 2021 Mac Keith Press
PY - 2021
Y1 - 2021
N2 - Aim: To describe the major congenital anomalies present in children with postneonatally acquired cerebral palsy (CP), and to compare clinical outcomes and cause of postneonatally acquired CP between children with and without anomalies. Method: Data were linked between total population CP and congenital anomaly registers in five European and three Australian regions for children born 1991 to 2009 (n=468 children with postneonatally acquired CP; 255 males, 213 females). Data were pooled and children classified into mutually exclusive categories based on type of congenital anomaly. The proportion of children with congenital anomalies was calculated. Clinical outcomes and cause of postneonatally acquired CP were compared between children with and without anomalies. Results: Major congenital anomalies were reported in 25.6% (95% confidence interval [CI] 21.7–29.9) of children with postneonatally acquired CP. Cardiac anomalies, often severe, were common and present in 14.5% of children with postneonatally acquired CP. Clinical outcomes were not more severe in children with congenital anomalies than those without anomalies. Cause of postneonatally acquired CP differed with the presence of congenital anomalies, with cerebrovascular accidents predominating in the anomaly group. Congenital anomalies were likely associated with cause of postneonatally acquired CP in 77% of children with anomalies. Interpretation: In this large, international study of children with postneonatally acquired CP, congenital anomalies (particularly cardiac anomalies) were common. Future research should determine specific causal pathways to postneonatally acquired CP that include congenital anomalies to identify opportunities for prevention.
AB - Aim: To describe the major congenital anomalies present in children with postneonatally acquired cerebral palsy (CP), and to compare clinical outcomes and cause of postneonatally acquired CP between children with and without anomalies. Method: Data were linked between total population CP and congenital anomaly registers in five European and three Australian regions for children born 1991 to 2009 (n=468 children with postneonatally acquired CP; 255 males, 213 females). Data were pooled and children classified into mutually exclusive categories based on type of congenital anomaly. The proportion of children with congenital anomalies was calculated. Clinical outcomes and cause of postneonatally acquired CP were compared between children with and without anomalies. Results: Major congenital anomalies were reported in 25.6% (95% confidence interval [CI] 21.7–29.9) of children with postneonatally acquired CP. Cardiac anomalies, often severe, were common and present in 14.5% of children with postneonatally acquired CP. Clinical outcomes were not more severe in children with congenital anomalies than those without anomalies. Cause of postneonatally acquired CP differed with the presence of congenital anomalies, with cerebrovascular accidents predominating in the anomaly group. Congenital anomalies were likely associated with cause of postneonatally acquired CP in 77% of children with anomalies. Interpretation: In this large, international study of children with postneonatally acquired CP, congenital anomalies (particularly cardiac anomalies) were common. Future research should determine specific causal pathways to postneonatally acquired CP that include congenital anomalies to identify opportunities for prevention.
UR - http://www.scopus.com/inward/record.url?scp=85099091633&partnerID=8YFLogxK
U2 - 10.1111/dmcn.14805
DO - 10.1111/dmcn.14805
M3 - Article
C2 - 33432582
AN - SCOPUS:85099091633
VL - 63
SP - 421
EP - 428
JO - Developmental Medicine & Child Neurology
JF - Developmental Medicine & Child Neurology
SN - 0012-1622
IS - 4
ER -